BioSpace News Archive

Deals

Harvard Bioscience Pays $70M for Data Sciences International and Sells Denville Scientific

DSI is a life science research company focused on delivering preclinical products, systems, services and solutions to its customers.

January 23, 2018
·
13 min read
Biotech Bay

Adamas Announces Proposed Public Offering of Common Stock

The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

January 23, 2018
·
2 min read
Pharm Country

Stemline Therapeutics Announces Proposed Public Offering of Common Stock

In addition, Stemline intends to grant the underwriters a 30-day option to purchase up to an additional 555,000 shares of its common stock offered in the public offering.

January 23, 2018
·
4 min read
Pharm Country

Insmed Announces Proposed Public Offering of Convertible Senior Notes

The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

January 23, 2018
·
9 min read
Business

TLC and Jixi Biotechnology Partners Announce Joint Venture

The new partnership’s efforts will take place pursuant to recent reforms by the CFDA, which include initiatives designed to accelerate drug approvals and encourage innovation, including greater alignment of China’s review process with that of the US and the EU.

January 23, 2018
·
3 min read
Drug Development

GENFIT: Official Launch of the NASH Pediatric Program, Following PIP and PSP Agreement by EMA and FDA

The PSP agreement by the FDA will lead to the launch of the first pediatric trial to evaluate the safety and efficacy of elafibranor in children with NASH.

January 23, 2018
·
7 min read
Profounda Launches Rhinase Baby Lubricating Nasal Drops

Profounda announced today that Rhinase Baby Lubricating Nasal Drops is now available in the United States through Rhinase.com and Amazon.com as well as on retail shelves at Kinney Drugs. Patients can also ask their Pharmacists to order Rhinase products directly from Profounda or Cardinal Health.

January 23, 2018
·
2 min read
Biotech Bay

Amarantus Subsidiary Cutanogen Corporation Announces Issuance of U.S. Patent 14/299

Once approved, ESS is eligible for 12 years of market exclusivity under the BPCIA.

January 23, 2018
·
6 min read
Business

Cynata Executes MoU for Commercial Evaluation With Celularity

Cynata has entered into a MoU with Celularity, for the commercial evaluation of Cynata’s Cymerus production technology for use with Celularity’s therapeutic stem cell technologies.

January 23, 2018
·
6 min read
Drug Development

Nohla Therapeutics Granted Orphan Drug Designation in the European Union for NLA101 in the Treatment of Hematopoietic Stem Cell Transplantation

The primary endpoint of the Phase 2b study is time to engraftment with an absolute neutrophil count (ANC) ≥ 500.

January 23, 2018
·
4 min read